InnovAge Holding earnings release, May 5, 2026

InnovAge Holding Corp. (INNV) · Form 8-K, Item 2.02 · Filed · SEC filing

INNOVAGE ANNOUNCES FINANCIAL RESULTS FOR THE

FISCAL THIRD QUARTER ENDED MARCH 31, 2025

DENVER, CO., May 5, 2026

(GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge” or the “Company”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail, predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), today announced financial results for its fiscal third quarter ended March 31, 2026.

We delivered a solid third quarter, reflecting continued improvement in operating execution and financial performance,” said Patrick Blair, Chief Executive Officer of InnovAge. “These results are being driven by stronger performance across our centers and the benefits of the investments we’ve made over the past several years to strengthen our platform. At the same time, we continue reinvesting in our clinical teams, technology, and quality capabilities to further improve participant outcomes and experience over the long term. Based on our performance year to date, we are raising our fiscal 2026 revenue and Adjusted EBITDA guidance.

Financial Results

Fiscal Third Quarter 2026 Financial Performance

• Total revenues of $251.9 million, increased approximately 15.5% compared to $218.1 million in the third quarter of fiscal year 2025

• Loss Before Income Taxes of $29.8 million decreased approximately 169.2%, compared to a Loss Before Income Taxes of $11.1 million in the third quarter of fiscal year 2025

• Loss Before Income Taxes as a percent of revenue was 11.8%, an increase of 6.7 percentage points, compared to Loss Before Income Tax as a percent of revenue of 5.1% in the third quarter of fiscal year 2025

• Center-level Contribution Margin

Financial statements

Income Statement

Three Months Ended March 31, — Financial Results (in thousands)

Three Months Ended March 31, – 2026Three Months Ended March 31, – 2025
Total revenues251,943218,142
Loss Before Income Taxes-29,773-11,061
Net Loss-29,940-11,133
Net Loss margin-11.9%-5.1%
Net Loss Attributable to InnovAge Holding Corp.-29,461-11,378
Net Loss per share - basic and diluted-0.22-0.08
Center-level Contribution Margin(1)61,02040,747
Adjusted EBITDA(1)30,49510,792
Adjusted EBITDA margin(1)12.1%4.9%

Income Statement

Revised Guidance – Low – dollars in millionsRevised Guidance – High – dollars in millions
Census7,9008,100
Total Member Months(1)92,90095,700
Total revenues950975
Adjusted EBITDA(2)8590

Income Statement

Three Months Ended March 31, — (IN THOUSANDS, EXCEPT NUMBER OF SHARES AND PER SHARE DATA) (UNAUDITED)

Three Months Ended March 31, – 2026Three Months Ended March 31, – 2025
RevenuesCapitation revenue251,502217,819
RevenuesOther service revenue441323
RevenuesTotal revenues251,943218,142
ExpensesExternal provider costs113,247107,896
ExpensesCost of care, excluding depreciation and amortization77,67669,499
ExpensesSales and marketing8,7446,922
ExpensesCorporate, general and administrative76,53138,597
ExpensesDepreciation and amortization4,8245,386
ExpensesTotal expenses281,022228,300
ExpensesOperating Loss-29,079-10,158
Other Income (Expense)Interest expense, net-988-1,160
Other Income (Expense)Other income, net294257
Other Income (Expense)Total other expense-694-903
Other Income (Expense)Loss Before Income Taxes-29,773-11,061
Other Income (Expense)Provision for Income Taxes16772
Other Income (Expense)Net Loss-29,940-11,133
Other Income (Expense)Less: net income (loss) attributable to noncontrolling interests-479245
Other Income (Expense)Net Loss Attributable to InnovAge Holding Corp.-29,461-11,378
Other Income (Expense)Weighted-average number of common shares outstanding - basic135,704,645135,200,314
Other Income (Expense)Weighted-average number of common shares outstanding - diluted135,704,645135,200,314
Other Income (Expense)Net loss per share - basic-0.22-0.08
Other Income (Expense)Net loss per share - diluted-0.22-0.08

Income Statement

Three months ended March 31, — Adjusted EBITDA

Three months ended March 31, – 2026Three months ended March 31, – 2025
Net loss-29,940-11,133
Interest expense, net9881,160
Other investment income(a)-294-503
Depreciation and amortization4,8245,386
Provision for income tax16772
Stock-based compensation1,7902,035
Litigation costs and settlement(b)51,85913,277
M&A diligence, transaction and integration(c)202
Business optimization(d)1,101152
Impairments and loss on assets held for sale(e)144
Adjusted EBITDA30,49510,792
Net income (loss) margin-11.9-5.1
Adjusted EBITDA margin12.14.9

Income Statement

Three months ended December 31,

Three months ended December 31, – 2025
Net income11,805
Interest expense, net1,246
Other investment income(a)-483
Depreciation and amortization4,877
Provision for income tax651
Stock-based compensation1,216
Litigation costs and settlement(b)1,279
Business optimization(c)1,560
Adjusted EBITDA22,151
Net income margin4.9
Adjusted EBITDA margin9.2

Income Statement

Three Months Ended March 31, 2026 — Center-Level Contribution Margin (in thousands)

Three Months Ended March 31, 2026 – PACEThree Months Ended March 31, 2026 – TotalsThree Months Ended March 31, 2025 – PACEThree Months Ended March 31, 2025 – All other(a)Three Months Ended March 31, 2025 – Totals
Capitation revenue251,502251,502217,819217,819
Other service revenue44144179244323
Total revenues251,943251,943217,898244218,142
External provider costs113,247113,247107,896107,896
Cost of care, excluding depreciation and amortization77,67677,67669,37212769,499
Center-Level Contribution Margin61,02061,02040,63011740,747
Sales and marketing8,7446,922
Corporate, general and administrative76,53138,597
Depreciation and amortization4,8245,386
Operating loss-29,079-10,158
Other expense-694-903
Loss Before Income Taxes-29,773-11,061
Loss Before Income Taxes as a percent of revenue-11.8-5.1
Center- Level Contribution Margin as a % of revenue24.218.7

Income Statement

December 31, 2025 — Center-Level Contribution Margin (in thousands)

December 31, 2025 – PACEDecember 31, 2025 – All other(1)December 31, 2025 – Totals
Capitation revenue239,620239,620
Other service revenue8888
Total revenues239,708239,708
External provider costs111,999111,999
Cost of care, excluding depreciation and amortization74,902-1874,884
Center-Level Contribution Margin52,8071852,825
Sales and marketing8,078
Corporate, general and administrative26,608
Depreciation and amortization4,877
Operating income (loss)13,262
Other expense-806
Income Before Income Taxes12,456
Income Before Income Taxes as a % of revenue5.2
Center- Level Contribution Margin as a % of revenue22

Balance Sheet

(IN THOUSANDS, EXCEPT NUMBER OF SHARES) (UNAUDITED)

March 31, 2026June 30, 2025
Current AssetsCash and cash equivalents95,53664,129
Current AssetsShort-term investments43,05241,775
Current AssetsRestricted cash1011
Current AssetsAccounts receivable28,58436,373

Cash Flow

Nine Months Ended March 31, — (IN THOUSANDS) (UNAUDITED) (in thousands)

Nine Months Ended March 31, – 2026Nine Months Ended March 31, – 2025
Operating ActivitiesNet loss-10,466-30,334
Adjustments to reconcile net loss to net cash provided by operating activities(Gain) loss on disposal of assets-478260
Adjustments to reconcile net loss to net cash provided by operating activitiesProvision for uncollectible accounts524
Adjustments to reconcile net loss to net cash provided by operating activitiesDepreciation and amortization14,78616,116
Adjustments to reconcile net loss to net cash provided by operating activitiesOperating lease rentals4,6034,738
Adjustments to reconcile net loss to net cash provided by operating activitiesImpairments and loss on assets held for sale1048,495
Adjustments to reconcile net loss to net cash provided by operating activitiesAmortization of deferred financing costs532322
Adjustments to reconcile net loss to net cash provided by operating activitiesStock-based compensation5,3146,069
Adjustments to reconcile net loss to net cash provided by operating activitiesDeferred income taxes521509
Adjustments to reconcile net loss to net cash provided by operating activitiesOther, net2,0391,173
Changes in operating assets and liabilitiesAccounts receivable7,7893,183
Changes in operating assets and liabilitiesPrepaid expenses and other current assets-7,566-6,275
Changes in operating assets and liabilitiesIncome tax receivable-77
Changes in operating assets and liabilitiesDeposits and other-2,053-4,471
Changes in operating assets and liabilitiesAccounts payable and accrued expenses28,46420,062
Changes in operating assets and liabilitiesReported and estimated claims2,3956,278
Changes in operating assets and liabilitiesDue to Medicaid and Medicare1,9372,125
Changes in operating assets and liabilitiesOperating lease liabilities-4,694-4,909
Changes in operating assets and liabilitiesDeferred revenue275
Changes in operating assets and liabilitiesNet cash provided by operating activities43,42523,865
Investing ActivitiesPurchases of property and equipment-10,043-6,442
Investing ActivitiesPurchases of short-term investments-1,193-1,610
Investing ActivitiesProceeds from sale of assets held for sale3,716
Investing ActivitiesProceeds from sale of short-term investments6,300
Investing ActivitiesAcquisition of business-4,774
Investing ActivitiesNet cash used in investing activities-7,520-6,526
Financing ActivitiesPayments for finance lease obligations-4,002-3,147
Financing ActivitiesPrincipal payments on long-term debt-61,280-2,848
Financing ActivitiesProceeds from the issuance of long-term debt60,082
Financing ActivitiesPayments on financing costs-1,989
Financing ActivitiesRepurchase of equity securities-7,024
Financing ActivitiesContribution from joint venture partner3,200
Financing ActivitiesTaxes paid related to net settlements of stock-based compensation awards-428-814
Financing ActivitiesNet cash used in financing activities-4,417-13,833
Full release

(1) of $61.0 million, increased 49.8% compared to $40.7 million in the third quarter of fiscal year 2025

• Center-level Contribution Margin

(1) as a percent of revenue was 24.2%, an increase of 5.5 percentage points compared to 18.7% in the third quarter of fiscal year 2025

• Net loss of $29.9 million, compared to net loss of $11.1 million in the third quarter of fiscal year 2025

• Net loss margin of 11.9%, an increase of 6.8 percentage points, compared to a net loss margin of 5.1% in the third quarter of fiscal year 2025

• Net loss attributable to InnovAge Holding Corp. of $29.5 million, or loss per share of $0.22, compared to net loss attributable to InnovAge Holding Corp. of $11.4 million, or a loss per share of $0.08 in the third quarter of fiscal year 2025

• Adjusted EBITDA

(1) of $30.5 million, an increase of $19.7 million, compared to Adjusted EBITDA of $10.8 million in the third quarter of fiscal year 2025

• Adjusted EBITDA

(1) margin of 12.1%, an increase of 7.2 percentage points, compared to 4.9% in the third quarter of fiscal year 2025

• Census of approximately 8,050 participants compared to 7,530 participants in the third quarter of fiscal year 2025

• Ended the third quarter of fiscal year 2026 with $95.5 million in cash and cash equivalents plus $43.1 million in short-term investments, and $69.4 million in debt on the balance sheet, representing debt under the Company’s senior secured term loan, revolving credit facility and finance lease obligations

(1)

Center-level Contribution Margin and Center-level Contribution Margin as a percentage of revenue, Adjusted EBITDA and Adjusted EBITDA margin are non-GAAP measures. For more details and for a definition and reconciliation of these non-GAAP measures to the most closely comparable GAAP measures for the periods indicated, see “Note Regarding Use of Non-GAAP Financial Measures” and “Reconciliation of GAAP and Non-GAAP Measures” below.

Full Fiscal Year 2026 Financial Guidance

Based on information as of today, May 5, 2026, InnovAge is raising total revenues and Adjusted EBITDA guidance for the full year fiscal 2026. Census and Total Member Months remain unchanged.

Expected results and estimates may be impacted by factors outside the Company’s control, and actual results may be materially different from this guidance. See “Forward-Looking Statements - Safe Harbor” included herein.

(1)

We define Total Member Months as the total number of participants as of period end multiplied by the number of months within a year in which each participant was enrolled in our program. Management believes this is a useful metric as it more precisely tracks the number of participants the Company serves throughout the year.

(2)

Adjusted EBITDA is a non-GAAP measure. See “Note Regarding Use of Non-GAAP Financial Measures” and “Reconciliation of GAAP and Non-GAAP Measures” for a definition of Adjusted EBITDA and a reconciliation to net income (loss), the most closely comparable GAAP measure. The Company is unable to provide guidance for net income (loss) or a reconciliation of the Company’s Adjusted EBITDA guidance because it cannot provide a meaningful or accurate calculation or estimation of certain reconciling items without unreasonable effort. The Company’s inability to do so is due to the inherent difficulty in forecasting and quantifying certain amounts that are necessary for such reconciliation, including variations in effective tax rate, expenses to be incurred for acquisition activities and other one-time or exceptional items.

Conference Call

The Company will host a conference call this afternoon at 5:00 PM Eastern Time. A live audio webcast of the call will be available on the Company’s website, https://investor.innovage.com. A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call, at the same web link, and will remain available for a limited time. To access the call by phone, please go to this link ( registration link), for dialing instructions and a unique access pin. We encourage participants to dial into the call fifteen minutes ahead of the scheduled start time.

About InnovAge... (truncated)nantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE). With a mission of enabling older adults to age independently in their own homes for as long as safely possible, InnovAge’s patient-centered care model is designed to improve the quality of care our participants receive while reducing over-utilization of high-cost care settings. InnovAge believes its PACE healthcare model is one in which all constituencies — participants, their families, providers and government payors — “win.” As of March 31, 2026, InnovAge served approximately 8,050 participants across 20 centers in six states. https://www.innovage.com.

Investor Contact:

Ryan Kubota rkubota@innovage.com

Media Contact: press@innovage.com

Forward-Looking Statements - Safe Harbor

This press release may contain “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as: “anticipate,” “estimate,” “expect,” “project,” “plan,” “intend,” “believe,” “may,” “will,” “should,” “can have,” “likely” and other words and terms of similar meaning in connection with any discussion of the timing or nature of future operating or financial performance or other events.

Forward-looking statements may be identified by the fact that they do not relate strictly to historical or current facts. Examples of forward-looking statements include, among others, statements we may make regarding quarterly or annual guidance; financial outlook, including future revenues and future earnings; mid-term and long-term financial goals; the viability of our growth strategy including our ability or expectations to increase the number of participants we serve, build and/or open de novo centers, or to identify and execute tuck-in acquisitions, joint ventures and other strategic partnerships; the expected impact of government policies including rate pressures resulting from Medicaid budget cuts, and the macroeconomic environment; our ability to control costs, mitigate the effects of elevated expenses or reduced healthcare budgets, expand our payer capabilities, execute clinical value and operational value initiatives and strengthen enterprise functions; and the effects of any of the foregoing on our future results of operations or financial conditions.

Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control and may cause our actual results and financial condition to differ materially. Important factors that could cause our actual results and financial condition to differ materially include, among others, the following: (i) the viability of our growth strategy, including our ability to find suitable geographies for new centers and to attract new participant and retain existing participants in new and existing centers and our ability to obtain licenses to open such centers; (ii) our ability to identify, successfully complete and integrate acquisitions, joint ventures another strategic partnerships; (iii) the impact of state and federal efforts to reduce healthcare spending, including recent legislation reducing the budget that funds Medicaid (iv) the impact on our business from macroeconomic related challenges, including labor shortages and labor competition; (v) inspections, reviews, audits and investigations under the federal and state government programs, including our ability to sufficiently cure any deficiencies identified; (vi) legal proceedings, enforcement actions and litigation and disputes; (vii) the risk that the cost of providing services will exceed our compensation, which we assume under our PACE contracts; (viii) the dependence of our revenues upon a limited number of government payors, including the risk of sudden loss of any of our government contracts; (ix) the risk that our submissions to government payors may contain inaccurate or unsupportable information, including regarding risk adjustment scores of participants, subjecting us to repayment obligations or penalties; (x) and our ability to comply with the continued listing requirements of Nasdaq.

Forward-looking statements are based only on information currently available to us and speaks only as of the date on which they are made. Except as required by law, we undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise. We advise you not to place undue reliance on forward-looking statements and to review our risk factors and other disclosures included in the reports we file or furnish with the Securities and Exchange Commission, including our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K.

Note Regarding Use of Non-GAAP Financial Measures... (truncated)help investors and analysts in comparing our results across reporting periods on a consistent basis by excluding items that we do not believe are indicative of our core operating performance.

The Company’s management uses Center-level Contribution Margin as the measure for assessing performance of its operating segments and allocating resources, predominantly in the annual budget and forecasting process. For the purpose of evaluating Center-level Contribution Margin on a center-by-center basis, we do not allocate our sales and marketing expense or corporate, general and administrative expenses across our centers. We define Center-level Contribution Margin as total revenues less external provider costs and cost of care, excluding depreciation and amortization, which includes all medical and pharmacy costs.

We define Adjusted EBITDA as net income (loss) adjusted for interest expense, net, other investment income, depreciation and amortization, and provision (benefit) for income tax as well as addbacks for non-recurring expenses or exceptional items, including charges relating to management equity compensation, litigation costs and settlement, M&A diligence, transaction and integration, business optimization, impairments and loss on assets held for sale, and loss (gain) on sale of assets. Adjusted EBITDA margin is Adjusted EBITDA expressed as a percentage of our total revenue.

Schedule 1

From SEC EDGAR. Analysis by Pear Digitals from the filing alone. Not investment advice. · InnovAge Holding earnings · Latest earnings · Markdown

Screener

Plans

Premium and Pro coming soon.

Log in

New here?

Join the waitlist

Pear FMV opens to everyone soon. We'll email you when it does.